Special Issue - Call for Papers
International Journal of Tumor Therapy
Complementary and alternative treatment strategies for tumor

Submission deadline: 12/31/2012

Scope and purposes

“International Journal of Tumor Therapy” is the Official Journal of the Scientific & Academic Publishing (SAP), an international journal publishing critical reviews, original research, research notes, debate and short reports and research remarks on experimental, clinical and computational tumor / cancer research.

Tumor is an anomalous growth of body/organ tissue and it can be cancerous (malignant) or noncancerous (benign). Cancer is a most important public health problem worldwide. Scientific evidences suggest that about 22.2 million cancer cases expected to occur in 2030. Cancer is treated with surgery, radiation, chemotherapy, hormone therapy, biological and targeted therapies. There is a need for the development of complementary and alternative treatment for tumor. Tumor therapy is an emerging field with potential applications for human health, such as innovative anticancer drugs, new cancer vaccines, photodynamic and radiation therapy of tumors. Tumor therapy aims to address a wide range of pharmacologic and oncologic concerns, cell and molecular biology of tumors, experimental therapeutics, carcinogenesis, oncogenes, genomics and proteomics.

The aim of the special issue is to assemble original research articles, critical reviews, research notes, debate and short reports in the areas of complementary and alternative treatment strategies for tumor, which offer huge insights in understanding important biological processes, with particular emphasis on diagnosis and treatment of disease of tumor. A central premise of the special issue is to cover interdisciplinary research areas of novel tumor / cancer treatment strategies, pharmacologic and oncologic concerns, toxicology, experimental and in-silico screening of new antitumor agents, drug administration, preclinical and clinical trials in oncology.

Topics of primary interest include, but are not limited to:
• Anti-tumor Treatments
• Molecular and cell biology of tumors
• Cancer Clinical Trials
• Cancer Etiology
• Cancer Genomics and proteomics
• Cancer Treatment Integrated Medicine
• Cancer Vaccines
• Clinical Trials in Oncology
• Complications of Treatment
• Experimental Therapeutics
• Follow-up Care After Cancer Treatment
• Human Immunology
• Hyperthermia in Cancer Treatment
• New Drugs
• Photodynamic Therapy for Cancer
• Radiation Therapy for Cancer
• Sentinel Lymph Node Biopsy
• Targeted Cancer Therapies
• Target Identification and Validation
• Computational prediction/analysis
• Biomarkers and molecular signatures
• Tumor microenvironment
• Regulatory pathways
• Translational therapeutics
• Molecular diagnostics of tumor
• Carcinogenesis
• Radiation biology
• Molecular pathology
• Hormones and cancer
• Viral oncology

Important Dates
Deadline for submission: 12/31/2012
Deadline for revision: 03/14/2013
Notification of final decision: 03/21/2013
Camera-Ready Final Manuscript Due: 03/31/2013
Estimated Publication: 2013 (Tentative)

Abstracts addressing one or more of these themes/topics or further questions should be emailed to an editor by <12/31/2012>.
Manuscript submissions are invited by the submission deadline. All papers will undergo a double or triple-blind peer review process.

Guest Editors
Dr. P. SRINIVASAN,sri.bioinformatics@gmail.com

Manuscript submission deadline 12/31/2012


Just enter your email address below,we will share with you the latest information of journals published by SAP. Plus, you can easily unsubscribe at any time, and we'll never share your email address with anyone.